2.84
3.27%
0.09
시간 외 거래:
2.95
0.11
+3.87%
전일 마감가:
$2.75
열려 있는:
$2.77
하루 거래량:
17,234
Relative Volume:
0.10
시가총액:
$3.71M
수익:
$12.31M
순이익/손실:
$-5.08M
주가수익비율:
-1.8684
EPS:
-1.52
순현금흐름:
$-5.20M
1주 성능:
-2.07%
1개월 성능:
+2.16%
6개월 성능:
-8.97%
1년 성능:
-23.61%
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
소노마 파머 주식(SNOA)의 최신 뉴스
Certain Options of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Certain Restricted Stock Units of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Certain Warrants of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Certain Preferred stock of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - AccessWire
Sonoma Pharmaceuticals, Inc. to Exhibit At MEDICA 2024 in Dusseldorf - Marketscreener.com
Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com
Unveiling the Future: Animal Wound Care Market to USD 1.24 BILLION IN 2023, Forecast by 2030, Featuring a C... - WhaTech
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - AccessWire
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - AccessWire
Scar Treatment Market to See Booming Growth 2024-2031 | Bausch - openPR
Keloid Treatment Market Latest Report 2023-2031 - InsightAce Analytic
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Recent Developments in the Eye Skin Care Market - openPR
Keloid Treatment Market: Insights Predicting a $4.72 Billion Valuation by 2031 - WhaTech
Hypertrophic Scar Treatment Market Growth, Trends, and Industry Share Analysis (2024-2032) - News in Assen
Sonoma Pharmaceuticals (SNOA) Shares Surge Amid Positive Market Activity - GuruFocus.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Williams-Sonoma, Inc. (WSM) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
South Korea Topical scar treatment Market Size & Outlook, 2030 - Grand View Research
Mexico Topical scar treatment Market Size & Outlook, 2030 - Grand View Research
Scar Treatment Market Top Industry Players – Perrigo Company, Smith & Nephew, Alliance Pharma, Rej√ªvaskin - Cauverynews
Sonoma Pharmaceuticals (SNOA) Stock Rises Amid Financial Report Insights - GuruFocus.com
Williams-Sonoma (WSM) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Scar Management Market Set to Grow at 5.61% CAGR, Projected to Reach $1.64 Billion by 2031 - WhaTech
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.86% - MSN
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above 200-Day Moving Average of $0.56 - MarketBeat
Here's Why Williams-Sonoma (WSM) Gained But Lagged the Market Today - Yahoo Finance
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
SONO’s latest rating updates from top analysts. - Knox Daily
Top investors say Sonos Inc (SONO) ticks everything they need - SETE News
15,500 Shares in Sonoco Products (NYSE:SON) Acquired by Skandinaviska Enskilda Banken AB publ - Defense World
Federated Hermes Inc. Sells 466 Shares of Sonoco Products (NYSE:SON) - Defense World
Intubation Tubes Market Report Details Growth Drivers, Opportunities, Share Report And Forecast To 2033 - WhaTech
Hypertrophic And Keloid Scar Treatment Market Advancements Highlighted by Size, Growth,Outlook Report 2033 - WhaTech
Scar Treatment Global Market Report 2024: Growth Drivers and Dynamics 2033 - WhaTech
Sei Investments Co. Has $75.60 Million Position in Sonoco Products (NYSE:SON) - Defense World
Ameritas Investment Partners Inc. Reduces Stock Position in Sonoco Products (NYSE:SON) - Defense World
Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule - MSN
AE Wealth Management LLC Buys 12,401 Shares of Sonoco Products (NYSE:SON) - Defense World
Richardson Financial Services Inc. Sells 1,295 Shares of Sonoco Products (NYSE:SON) - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
Sonoma Pharmaceuticals Inc. (SNOA)’s Day in Review: Closing at 3.83, Down by -10.93 - The Dwinnex
Financial Fitness Check: Examining Sonos Inc (SONO)’s Key Ratios - The Dwinnex
Keloid Treatment Market Poised for Growth, Expected to Reach USD 5.6 Billion by 2033 at a 3.8% of CAGR - Market Research Blog
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above 200-Day Moving Average of $0.33 - MarketBeat
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above Two Hundred Day Moving Average of $0.33 - Defense World
Sonoma Pharmaceuticals regains Nasdaq compliance - Investing.com
MQS Management LLC Purchases 7,448 Shares of Sonoco Products (NYSE:SON) - Defense World
Sonoma Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - StockTitan
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):